rs149570245
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003002.4(SDHD):c.*260T>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0157 in 499,770 control chromosomes in the GnomAD database, including 462 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.038 ( 355 hom., cov: 32)
Exomes 𝑓: 0.0059 ( 107 hom. )
Consequence
SDHD
NM_003002.4 3_prime_UTR
NM_003002.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.552
Publications
0 publications found
Genes affected
SDHD (HGNC:10683): (succinate dehydrogenase complex subunit D) This gene encodes a member of complex II of the respiratory chain, which is responsible for the oxidation of succinate. The encoded protein is one of two integral membrane proteins anchoring the complex to the matrix side of the mitochondrial inner membrane. Mutations in this gene are associated with the formation of tumors, including hereditary paraganglioma. Transmission of disease occurs almost exclusively through the paternal allele, suggesting that this locus may be maternally imprinted. There are pseudogenes for this gene on chromosomes 1, 2, 3, 7, and 18. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2013]
SDHD Gene-Disease associations (from GenCC):
- hereditary pheochromocytoma-paragangliomaInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- pheochromocytomaInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- pheochromocytoma/paraganglioma syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- Carney-Stratakis syndromeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
- mitochondrial complex II deficiency, nuclear type 1Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- renal cell carcinomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- mitochondrial complex 2 deficiency, nuclear type 3Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics
- mitochondrial complex II deficiencyInheritance: AR Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
- Cowden diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- intestinal cancerInheritance: AD Classification: LIMITED Submitted by: G2P
- mitochondrial diseaseInheritance: AR Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 11-112095230-T-A is Benign according to our data. Variant chr11-112095230-T-A is described in ClinVar as Benign. ClinVar VariationId is 165184.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.128 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SDHD | NM_003002.4 | c.*260T>A | 3_prime_UTR_variant | Exon 4 of 4 | ENST00000375549.8 | NP_002993.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0380 AC: 5779AN: 152186Hom.: 354 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
5779
AN:
152186
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00592 AC: 2056AN: 347466Hom.: 107 Cov.: 0 AF XY: 0.00483 AC XY: 885AN XY: 183196 show subpopulations
GnomAD4 exome
AF:
AC:
2056
AN:
347466
Hom.:
Cov.:
0
AF XY:
AC XY:
885
AN XY:
183196
show subpopulations
African (AFR)
AF:
AC:
1493
AN:
10790
American (AMR)
AF:
AC:
115
AN:
15532
Ashkenazi Jewish (ASJ)
AF:
AC:
45
AN:
11264
East Asian (EAS)
AF:
AC:
26
AN:
23412
South Asian (SAS)
AF:
AC:
17
AN:
42430
European-Finnish (FIN)
AF:
AC:
3
AN:
15782
Middle Eastern (MID)
AF:
AC:
9
AN:
1444
European-Non Finnish (NFE)
AF:
AC:
117
AN:
206364
Other (OTH)
AF:
AC:
231
AN:
20448
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
94
188
281
375
469
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0380 AC: 5791AN: 152304Hom.: 355 Cov.: 32 AF XY: 0.0376 AC XY: 2803AN XY: 74484 show subpopulations
GnomAD4 genome
AF:
AC:
5791
AN:
152304
Hom.:
Cov.:
32
AF XY:
AC XY:
2803
AN XY:
74484
show subpopulations
African (AFR)
AF:
AC:
5446
AN:
41544
American (AMR)
AF:
AC:
198
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
19
AN:
3472
East Asian (EAS)
AF:
AC:
15
AN:
5186
South Asian (SAS)
AF:
AC:
2
AN:
4832
European-Finnish (FIN)
AF:
AC:
1
AN:
10632
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
53
AN:
68026
Other (OTH)
AF:
AC:
56
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
261
523
784
1046
1307
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
25
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 15, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
Nov 05, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Pheochromocytoma Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.